“Omalizumab plus”: Combining omalizumab with immunosuppression for treatment of refractory chronic urticaria: A multicenter UK series

Publication date: March 2021Source: The Journal of Allergy and Clinical Immunology: In Practice, Volume 9, Issue 3Author(s): Krzysztof Rutkowski, Annette Wagner, Karen Jui-Lin Choo, Helin Smith, Sinisa Savic, Clive E. Grattan

Source: The Journal of Allergy and Clinical Immunology: In Practice - March 5, 2021 Category: Allergy & Immunology Source Type: research